NORTHWELL HEALTH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1997-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.northwell.edu/
Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis
- First Posted Date
- 2015-06-11
- Last Posted Date
- 2016-08-12
- Lead Sponsor
- Northwell Health
- Target Recruit Count
- 46
- Registration Number
- NCT02469597
- Locations
- 🇺🇸
Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York, United States
Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study
Phase 1
Withdrawn
- Conditions
- Non-alcoholic Fatty Liver Disease (NAFLD)
- Interventions
- First Posted Date
- 2015-05-29
- Last Posted Date
- 2017-07-28
- Lead Sponsor
- Northwell Health
- Registration Number
- NCT02457286
- Locations
- 🇺🇸
North Shore Hospital, Manhasset, New York, United States
Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus
Completed
- Conditions
- Systemic Lupus Erythematosus
- First Posted Date
- 2015-05-28
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- Northwell Health
- Target Recruit Count
- 30
- Registration Number
- NCT02456168
- Locations
- 🇺🇸
The Feinstein Institute for Medical Research, Manhasset, New York, United States
Erythrocyte Ghost Mediated Retinal Diagnosis
Not Applicable
Withdrawn
- Conditions
- Retinal Disease
- Interventions
- Procedure: ICG loaded erythrocytes
- First Posted Date
- 2015-05-15
- Last Posted Date
- 2016-01-22
- Lead Sponsor
- Northwell Health
- Registration Number
- NCT02445001
- Locations
- 🇺🇸
Northshore LIJ/MEETH Campus, New York, New York, United States
Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck
Phase 1
Terminated
- Conditions
- Carcinoma, Squamous Cell of Head and NeckCarcinoma, Squamous Cell
- Interventions
- Drug: Intraarterial Cetxuimab (Erbitux)
- First Posted Date
- 2015-05-08
- Last Posted Date
- 2021-11-03
- Lead Sponsor
- Northwell Health
- Target Recruit Count
- 11
- Registration Number
- NCT02438995
- Locations
- 🇺🇸
Lenox Hill Hospital, New York, New York, United States
HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
Phase 1
Completed
- Conditions
- Sickle Cell DiseaseBeta Thalassemia-Major
- Interventions
- Biological: Hematopoietic Stem Cell Transplantation
- First Posted Date
- 2015-05-06
- Last Posted Date
- 2021-08-24
- Lead Sponsor
- Northwell Health
- Target Recruit Count
- 29
- Registration Number
- NCT02435901
- Locations
- 🇺🇸
Cohen Children's Medical Center of New York, New Hyde Park, New York, United States
The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study
Not Applicable
Completed
- Conditions
- Chronic Schizophrenia
- Interventions
- Device: Transcranial direct current stimulationDevice: Transcranial direct current stimulation - Sham
- First Posted Date
- 2015-04-20
- Last Posted Date
- 2018-04-30
- Lead Sponsor
- Northwell Health
- Target Recruit Count
- 12
- Registration Number
- NCT02421146
- Locations
- 🇺🇸
Zucker Hillside Hospital, Glen Oaks, New York, United States
Comparing Voiding Trials After Midurethral Sling for Stress Incontinence
Not Applicable
Completed
- Conditions
- Urethral HypermobilityStress Urinary IncontinenceCystocele
- Interventions
- Other: Voiding trial
- First Posted Date
- 2015-03-26
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Northwell Health
- Target Recruit Count
- 112
- Registration Number
- NCT02400034
- Locations
- 🇺🇸
Urogynecology, Female Pelvic Medicine and Reconstructive Surgery, Great Neck, New York, United States
A Trial to Evaluate Negative Pressure Incision Management System for Groin Wounds in Vascular Surgery Patients
Not Applicable
Terminated
- Conditions
- Surgical Procedure, Unspecified
- Interventions
- Device: Prevena Incision Management System
- First Posted Date
- 2015-03-26
- Last Posted Date
- 2016-11-21
- Lead Sponsor
- Northwell Health
- Target Recruit Count
- 9
- Registration Number
- NCT02399111
- Locations
- 🇺🇸
North Shore-LIJ Health System, Lake Success, New York, United States
Gallium-68 DOTATOC for Management of Neuroendocrine Tumors
- Conditions
- Neuroendocrine Tumors
- First Posted Date
- 2015-03-02
- Last Posted Date
- 2016-11-08
- Lead Sponsor
- Northwell Health
- Registration Number
- NCT02375464
© Copyright 2025. All Rights Reserved by MedPath